ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mammana, R. B.
Right arrow Articles by Copeland, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mammana, R. B.
Right arrow Articles by Copeland, J. G.

The Annals of Thoracic Surgery, Vol 36, 700-705, Copyright © 1983 by The Society of Thoracic Surgeons


ARTICLES

Pulmonary infections in cardiac transplant patients: modes of diagnosis, complications, and effectiveness of therapy

RB Mammana, EA Petersen, JK Fuller, K Siroky and JG Copeland

Eighteen serious pulmonary infections have been encountered in 10 of 16 surviving cardiac transplant recipients. Fourteen of 18 infections (78%) occurred within the first six months after transplant and the remaining 4 (22%) after the first six months (p less than 0.05). There was no correlation between the number of rejections per patient and propensity toward infection. Transtracheal aspiration or percutaneous lung aspiration established the diagnosis in all but two episodes. Percutaneous lung aspiration appeared more accurate as a diagnostic tool but was associated with 6 complications in 13 attempts (46%), while no complications occurred in 17 attempts with transtracheal aspiration (p less than 0.05). Five of the 10 patients had multiple episodes of pulmonary infection; 2 of these 5 (40%) had concurrent infections. Nocardia organisms were encountered most frequently, accounting for 7 of 18 (39%) infections; 6 of 10 patients (60%) were infected with Nocardia at some point after transplant. Nine of 10 patients (90%) were cured of infection. Eight are still alive without evidence of infection. We conclude from these data that pulmonary infection is common in transplant recipients, that early definitive diagnosis, in spite of the potential complications, is warranted, and that cure of infection and long-term survival are possible if treatment is timely and aggressive.


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
W. T. Miller Jr. and R. M. Shah
Isolated Diffuse Ground-Glass Opacity in Thoracic CT: Causes and Clinical Presentations
Am. J. Roentgenol., February 1, 2005; 184(2): 613 - 622.
[Full Text] [PDF]


Home page
ChestHome page
R. Lenner, M. L. Padilla, A. S. Teirstein, A. Gass, and G. J. Schilero
Pulmonary Complications in Cardiac Transplant Recipients
Chest, August 1, 2001; 120(2): 508 - 513.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1983 by The Society of Thoracic Surgeons.